Krystal Biotech's IPO

Krystal Biotech raised a round of funding on September 20, 2017. Investors include Public.

Krystal Biotech is a biopharmaceutical company using gene therapy to develop treatments that provide clinical benefit for patients suffering form rare debilitating disorders.…

Articles about Krystal Biotech's IPO: